Theriva Biologics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $17.1M | $19.1M | $20.8M | $17.5M | $14.6M | $10.0M | $6.7M | — |
| Accounts Receivable | — | — | — | — | — | $0 | $405.0K | $339.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $17.9M | $21.6M | $30.3M | $19.1M | $16.2M | $12.5M | $7.1M | $3.5M |
| Property, Plant & Equipment | $872.0K | $905.0K | $494.0K | $65.0K | $37.0K | $223.0K | $323.0K | $475.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $18.8M | $22.5M | $30.8M | $19.1M | $16.3M | $13.4M | $7.5M | $4.1M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $2.0M | $4.4M | $996.0K | $142.0K | $395.0K | $388.0K | $266.0K |
| Total Current Liabilities | $9.8M | $19.8M | $15.6M | $9.6M | $1.0M | $395.0K | $417.0K | $500.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $10.2M | $20.2M | $15.8M | $9.6M | $1.0M | $395.0K | $417.0K | $532.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-194.2M | $-172.0M | $-144.8M | $-101.0M | $-81.3M | $-68.9M | $-51.9M | $-43.7M |
| Total Stockholders' Equity | $-1.5M | $3.8M | $16.1M | $9.6M | $15.2M | $13.0M | $7.1M | $3.6M |